AL
BLRX

Airain Ltd’s BioLineRX BLRX Stock Holding History

Airain Ltd’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24
Closed -$19K – 807
2015
Q4 		$19K Sell
24
-9
-27% -$7.47K ﹤0.01% 801
2015
Q3 		$30K Buy
+33
New +$35.2K ﹤0.01% 804

Other funds holding BLRX

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return

Airain Ltd's BLRX Position: Q1 2016 in Review

Airain Ltd sold out of BioLineRX (BLRX) in Q1 2016, closing a stake of 24 shares — an estimated $19K sold.

Airain Ltd first reported a position in BLRX in Q3 2015 and held it in 2 quarters. The position peaked at $30K in Q3 2015. 26 funds tracked by Wall St. Rank hold BLRX as of Q1 2016.

  • Airain Ltd reported no remaining BioLineRX position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 24 BioLineRX shares in Q1 2016, an estimated $19K.
  • Airain Ltd first reported a position in BioLineRX in Q3 2015 and held it in 2 quarters.
  • Airain Ltd's BioLineRX position peaked at $30K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held BioLineRX as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.